Sahin Boydas
Random theme
Select theme
Back to all articles
AI in HealthcareHow-To Guide

How to Navigate the FDA Approval Process for Your Medical AI (The 2026 Playbook)

I've got the scar tissue to prove it. A decade in the Valley, with a focus on healthcare AI, has taught me a few things. Here are the lessons from my wins, my (many) failures, and what I'm investing in now.

2024-12-017 min read593 words
Practical How-To Guide·6 steps·7 min read

I've got the scar tissue to prove it. A decade in the Valley, with a focus on healthcare AI, has taught me a few things. Here are the lessons from my wins, my (many) failures, and what I'm investing in now.

What I've Learned From 28 Companies

Across 234 angel investments, including Anthropic, a few patterns in FDA approval come up again and again.

The founders who handle FDA approval well understand that your team matters more than your technology.

Why Most Approaches Fail

Many common approaches to FDA approval are flawed at the root.

The root cause is usually one of three things:

Copying what big companies do without understanding why they do it. What works for Google doesn't work for a 10-person startup.

Over-engineering the solution when a simple approach would work better. I've seen teams spend six months building something that could have been done in two weeks.

Ignoring the human element. Technology is the easy part. Getting people to actually use it is where the real challenge lives.

The Counterintuitive Truth

In FDA approval, the best practitioners often do less, not more.

The lesson: your team matters more than your technology. It sounds simple. It's incredibly hard to execute.

Lessons From the Trenches

I want to share a few specific lessons I've picked up over the years. These aren't theoretical. They come from real companies, real failures, and real successes.

Lesson 1: The best time to start thinking about FDA approval was yesterday. The second best time is now. Don't wait until you have the perfect plan.

Lesson 2: Hire for attitude, train for skill. The best people at FDA approval are rarely the most technically gifted. They are the most curious and persistent.

Lesson 3: Your competitors are probably getting this wrong too. That's your opportunity. While everyone else is following the same playbook, you can zig when they zag.

This connects to broader themes around AI mental health, AI radiology, healthcare automation, medical AI that I've been thinking about a lot lately.

Wrapping Up

I've shared a lot here, and I know it can feel overwhelming. But you don't need to get FDA approval right on day one. You just need to get started and keep improving.

Founders who do well at FDA approval tend to share one trait: they're relentlessly practical. They don't chase perfection. They chase progress.

That's the mindset I'd encourage you to adopt. Start where you are. Use what you have. Do what you can. And keep pushing forward.

As always, I'm rooting for you.

FAQ

Frequently Asked Questions

Q:How long does it take to get FDA approval right?

The timeline varies depending on your starting point and resources. For most founders, expect 2-4 weeks for initial setup and 2-3 months to see meaningful results. I've seen teams move faster when they focus on one thing at a time rather than trying to do everything at once.

Q:What are the most common mistakes with FDA approval?

The biggest mistake I see is overcomplicating things early on. Start with the simplest version that works, get real feedback, and iterate from there. Another common trap is copying what worked for someone else without understanding the context behind their decisions.

Q:How do I measure success with this approach?

Pick one or two metrics that directly tie to your goal and track them weekly. Vanity metrics like page views or follower counts rarely matter. Focus on metrics that reflect real engagement or revenue impact.

Written by

Sahin Boydas

Serial entrepreneur, #1 angel investor, author of Becoming Top 1%

Get Sahin's Weekly Insights

Join 10,000+ founders and investors. One email per week with actionable advice on startups, investing, and building in the AI era.

No spam. Unsubscribe anytime.